Hu Xinli, Kim Hyun, Raj Towfique, Brennan Patrick J, Trynka Gosia, Teslovich Nikola, Slowikowski Kamil, Chen Wei-Min, Onengut Suna, Baecher-Allan Clare, De Jager Philip L, Rich Stephen S, Stranger Barbara E, Brenner Michael B, Raychaudhuri Soumya
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Partners Center for Personalized Genetic Medicine, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts, United States of America.
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Partners Center for Personalized Genetic Medicine, Boston, Massachusetts, United States of America.
PLoS Genet. 2014 Jun 26;10(6):e1004404. doi: 10.1371/journal.pgen.1004404. eCollection 2014 Jun.
Genome-wide association studies (GWAS) and subsequent dense-genotyping of associated loci identified over a hundred single-nucleotide polymorphism (SNP) variants associated with the risk of rheumatoid arthritis (RA), type 1 diabetes (T1D), and celiac disease (CeD). Immunological and genetic studies suggest a role for CD4-positive effector memory T (CD+ TEM) cells in the pathogenesis of these diseases. To elucidate mechanisms of autoimmune disease alleles, we investigated molecular phenotypes in CD4+ effector memory T cells potentially affected by these variants. In a cohort of genotyped healthy individuals, we isolated high purity CD4+ TEM cells from peripheral blood, then assayed relative abundance, proliferation upon T cell receptor (TCR) stimulation, and the transcription of 215 genes within disease loci before and after stimulation. We identified 46 genes regulated by cis-acting expression quantitative trait loci (eQTL), the majority of which we detected in stimulated cells. Eleven of the 46 genes with eQTLs were previously undetected in peripheral blood mononuclear cells. Of 96 risk alleles of RA, T1D, and/or CeD in densely genotyped loci, eleven overlapped cis-eQTLs, of which five alleles completely explained the respective signals. A non-coding variant, rs389862A, increased proliferative response (p=4.75 × 10-8). In addition, baseline expression of seventeen genes in resting cells reliably predicted proliferative response after TCR stimulation. Strikingly, however, there was no evidence that risk alleles modulated CD4+ TEM abundance or proliferation. Our study underscores the power of examining molecular phenotypes in relevant cells and conditions for understanding pathogenic mechanisms of disease variants.
全基因组关联研究(GWAS)以及随后对相关基因座进行的高密度基因分型,确定了一百多个与类风湿性关节炎(RA)、1型糖尿病(T1D)和乳糜泻(CeD)风险相关的单核苷酸多态性(SNP)变体。免疫学和遗传学研究表明,CD4阳性效应记忆T(CD + TEM)细胞在这些疾病的发病机制中起作用。为了阐明自身免疫病等位基因的机制,我们研究了可能受这些变体影响的CD4 + 效应记忆T细胞中的分子表型。在一组基因分型的健康个体中,我们从外周血中分离出高纯度的CD4 + TEM细胞,然后检测其相对丰度、T细胞受体(TCR)刺激后的增殖情况,以及刺激前后疾病基因座内215个基因的转录情况。我们鉴定出46个受顺式作用表达数量性状基因座(eQTL)调控的基因,其中大多数在刺激细胞中检测到。46个具有eQTL的基因中有11个以前在外周血单核细胞中未被检测到。在高密度基因分型基因座中的96个RA、T1D和/或CeD风险等位基因中,11个与顺式eQTL重叠,其中5个等位基因完全解释了各自的信号。一个非编码变体rs389862A增加了增殖反应(p = 4.75×10 - 8)。此外,静息细胞中17个基因的基线表达可靠地预测了TCR刺激后的增殖反应。然而,引人注目的是,没有证据表明风险等位基因调节CD4 + TEM的丰度或增殖。我们的研究强调了在相关细胞和条件下检查分子表型对于理解疾病变体致病机制的作用。